For example, the expression of calcium-sensing receptor (CaSR) is significantly increased in asthma patients, and its antagonist NPS2143 can alleviate asthma symptoms by reducing airway hyperresponsiveness (AHR) and inflammation [39, 40]. This evidence concerns the gene CASR and airway hyperresponsiveness.